A detailed history of Gryphon Financial Partners LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 1,250 shares of ELV stock, worth $501,200. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,250
Previous 1,268 1.42%
Holding current value
$501,200
Previous $687,000 5.39%
% of portfolio
0.09%
Previous 0.1%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$500.12 - $562.29 $9,002 - $10,121
-18 Reduced 1.42%
1,250 $650,000
Q2 2024

Aug 07, 2024

BUY
$497.49 - $547.8 $35,819 - $39,441
72 Added 6.02%
1,268 $687,000
Q1 2024

May 01, 2024

BUY
$464.61 - $519.96 $555,673 - $621,872
1,196 New
1,196 $620,000
Q3 2023

Nov 07, 2023

BUY
$414.13 - $475.93 $210,378 - $241,772
508 Added 126.68%
909 $395,000
Q2 2023

Aug 08, 2023

SELL
$436.33 - $496.2 $222,528 - $253,062
-510 Reduced 55.98%
401 $178,000
Q1 2023

May 03, 2023

SELL
$446.3 - $502.2 $31,241 - $35,154
-70 Reduced 7.14%
911 $418,000
Q4 2022

Feb 08, 2023

SELL
$465.23 - $546.77 $76,762 - $90,217
-165 Reduced 14.4%
981 $503,000
Q3 2022

Nov 14, 2022

SELL
$445.98 - $507.0 $26,312 - $29,913
-59 Reduced 4.9%
1,146 $521,000
Q2 2022

Jul 28, 2022

SELL
$444.32 - $529.84 $174,617 - $208,227
-393 Reduced 24.59%
1,205 $582,000
Q1 2022

May 05, 2022

BUY
$428.44 - $502.48 $10,711 - $12,562
25 Added 1.59%
1,598 $785,000
Q4 2021

Feb 01, 2022

SELL
$370.08 - $467.67 $74,756 - $94,469
-202 Reduced 11.38%
1,573 $729,000
Q3 2021

Nov 12, 2021

BUY
$357.51 - $398.13 $53,626 - $59,719
150 Added 9.23%
1,775 $662,000
Q2 2021

Aug 13, 2021

BUY
$352.19 - $401.9 $39,093 - $44,610
111 Added 7.33%
1,625 $461,000
Q1 2021

May 05, 2021

BUY
$287.7 - $371.31 $2,877 - $3,713
10 Added 0.66%
1,514 $543,000
Q4 2020

Feb 10, 2021

SELL
$270.17 - $333.15 $19,722 - $24,319
-73 Reduced 4.63%
1,504 $483,000
Q3 2020

Nov 16, 2020

BUY
$245.73 - $284.63 $66,592 - $77,134
271 Added 20.75%
1,577 $423,000
Q2 2020

Aug 13, 2020

BUY
$203.3 - $300.59 $265,509 - $392,570
1,306 New
1,306 $343,000
Q3 2018

Nov 06, 2018

SELL
$238.27 - $274.12 $34,787 - $40,021
-146 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$220.13 - $245.16 $440 - $490
-2 Reduced 1.35%
146 $35,000
Q1 2018

May 14, 2018

SELL
$215.63 - $258.19 $8,409 - $10,069
-39 Reduced 20.86%
148 $33,000
Q4 2017

Feb 09, 2018

BUY
$183.76 - $234.96 $34,363 - $43,937
187
187 $42,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $96.2B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Gryphon Financial Partners LLC Portfolio

Follow Gryphon Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.